COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?

Tadic, Marijana; Cuspidi, Cesare

Tadic, Marijana; Cuspidi, Cesare.

Tadic M; University Hospital "Dr. Dragisa Misovic - Dedinje" Department of Cardiology, Belgrade, Serbia.
Cuspidi C; University of Milan-Bicocca, Milan, Italy.

J Clin Hypertens (Greenwich) ; 22(11): 1984-1986, 2020 11.

Article in English | MEDLINE | ID: covidwho-780916

Subject(s)

Angiotensin Receptor Antagonists/adverse effects; Angiotensin-Converting Enzyme Inhibitors/adverse effects; COVID-19/diagnosis; Hypertension/drug therapy; Renin-Angiotensin System/drug effects; SARS-CoV-2/drug effects; Angiotensin Receptor Antagonists/therapeutic use; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Antihypertensive Agents/adverse effects; Antihypertensive Agents/therapeutic use; COVID-19/epidemiology; COVID-19/mortality; COVID-19/virology; Hospitalization/statistics & numerical data; Humans; Hypertension/complications; Hypertension/epidemiology; Hypertension/mortality; Intensive Care Units/statistics & numerical data; Prevalence; Respiration, Artificial/statistics & numerical data; Respiratory Distress Syndrome/epidemiology; Respiratory Insufficiency/epidemiology; Risk Factors; SARS-CoV-2/genetics; Severity of Illness Index; Shock, Septic/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renin-Angiotensin System / Angiotensin-Converting Enzyme Inhibitors / Angiotensin Receptor Antagonists / SARS-CoV-2 / COVID-19 / Hypertension Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Clin Hypertens (Greenwich) Journal subject: Vascular Diseases Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google